Call for Abstract

13th World Biomarkers Congress, will be organized around the theme “Role of Biomarkers in Early Detection and Prevention of Disease”

World Biomarkers 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in World Biomarkers 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Protien Biomarkers
  • Track 1-2Nucleic acid biomarkers
  • Track 1-3Lipid biomarkers
  • Track 1-4Small molecule biomarkers
  • Track 2-1Genetic biomarkers
  • Track 2-2Pathological biomarkers
  • Track 2-3In silico bioamarkers
  • Track 2-4Imaging biomarkers
  • Track 2-5Glycoprotien biomarkers
  • Track 3-1Clinical biomarkers in drug discovery
  • Track 3-2Clinical biomarkers in oncology
  • Track 3-3Clinical biomarkers and pharmacogenomics
  • Track 3-4Clinical biomarkers in diagnostics
  • Track 4-1Biomarkers for breast cancer
  • Track 4-2Biomarkers for lung cancer
  • Track 4-3Biomarkers for prostate cancer
  • Track 4-4Biomarkers for blood cancer
  • Track 4-5Biomarkers for adrenal cancer
  • Track 4-6Biomarkers for colorectal cancer
  • Track 4-7Biomarkers for gastric cancer
  • Track 5-1Biomarkers for Alzheimer’s
  • Track 5-2Biomarkers for Cardiovascular diseases
  • Track 5-3Biomarkers for Neurodegenerative diseases
  • Track 5-4Biomarkers for diabetes
  • Track 5-5Biomarkers for Huntington s disease
  • Track 5-6Biomarkers for Behcet s disease
  • Track 6-1New strategies for discovery
  • Track 6-2Protein biomarker discovery
  • Track 6-3Clinical biomarker advances
  • Track 6-4Biomarkers for paediatric diseases
  • Track 6-5Biomarkers for paediatric diseases
  • Track 6-6Clinical analysis of NGS samples
  • Track 6-7Mass spectrometry based biomarker discovery
  • Track 7-1Genetic testing and Molecular Biomarkers
  • Track 7-2Biomarker testing for cancers
  • Track 7-3Biomarker testing for other diseases
  • Track 7-4Biomarker testing in diagnosis
  • Track 8-1Diagnostic and prognostic biomarkers
  • Track 8-2Tumor biomarkers
  • Track 8-3Diagnosis and intervention
  • Track 8-4Drug development and usage
  • Track 8-5Cancer genomics
  • Track 8-6Challenges and probable solutions
  • Track 9-1Case reports on molecular biomarkers
  • Track 9-2Case reports on cancer biomarkers
  • Track 9-3Case reports on diagnostics
  • Track 9-4Case reports on drug discover
  • Track 9-5Case reports on imaging
  • Track 10-1In vitro companion diagnostics devices
  • Track 10-2Medical devices
  • Track 10-3Commercialization of companion diagnostics
  • Track 10-4Strategies for Rx-Dx partnerships
  • Track 10-5Strategies for Rx-Dx partnerships
  • Track 10-6Choosing a platform for companion diagnostics